Shopping Cart
- Remove All
- Your shopping cart is currently empty
CK2/ERK8-IN-1 (TMCB) is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 µM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy. CK2/ERK8-IN-1 also binds to PIM1, DYRK1A, and HIPK2 (Kis: 8.65 µM, 11.9 µM, and 15.25 µM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $30 | In Stock | |
10 mg | Inquiry | In Stock |
Description | CK2/ERK8-IN-1 (TMCB) is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 µM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy. CK2/ERK8-IN-1 also binds to PIM1, DYRK1A, and HIPK2 (Kis: 8.65 µM, 11.9 µM, and 15.25 µM). |
Targets&IC50 | ERK8:0.5 μM, Apoptosis:, DYRK1A:11.9 μM (ki), HIPK2:15.25 μM (ki), CK2:0.25 μM (ki), CK2:0.5 μM, Pim1:8.65 μM (ki) |
In vitro | In Jurkat cells, CK2/ERK8-IN-1 (Compound K66; 0-50 µM; 24 hours) treatment displays cytotoxic activity[1]. |
Alias | TMCB |
Molecular Weight | 534.82 |
Formula | C11H9Br4N3O2 |
Cas No. | 1085822-09-8 |
Smiles | CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2n1CC(O)=O |
Relative Density. | 2.40 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 1 mg/ml, Sonication is recommended. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.